NYSE - Nasdaq Real Time Price USD

ResMed Inc. (RMD)

218.06 +34.64 (+18.89%)
At close: April 26 at 4:00 PM EDT
218.83 +0.77 (+0.35%)
After hours: April 26 at 7:58 PM EDT
Key Events
Loading Chart for RMD
DELL
  • Previous Close 183.42
  • Open 203.02
  • Bid 217.76 x 800
  • Ask 217.95 x 900
  • Day's Range 201.92 - 218.38
  • 52 Week Range 132.24 - 240.09
  • Volume 4,035,969
  • Avg. Volume 1,070,944
  • Market Cap (intraday) 32.074B
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) 36.10
  • EPS (TTM) 6.04
  • Earnings Date Apr 25, 2024
  • Forward Dividend & Yield 1.92 (0.88%)
  • Ex-Dividend Date May 8, 2024
  • 1y Target Est 202.68

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.

www.resmed.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: RMD

Performance Overview: RMD

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RMD
27.08%
S&P 500
6.92%

1-Year Return

RMD
2.78%
S&P 500
25.26%

3-Year Return

RMD
6.84%
S&P 500
22.00%

5-Year Return

RMD
122.96%
S&P 500
74.29%

Compare To: RMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RMD

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    32.07B

  • Enterprise Value

    33.26B

  • Trailing P/E

    36.10

  • Forward P/E

    27.40

  • PEG Ratio (5yr expected)

    2.06

  • Price/Sales (ttm)

    7.14

  • Price/Book (mrq)

    7.16

  • Enterprise Value/Revenue

    7.38

  • Enterprise Value/EBITDA

    23.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.91%

  • Return on Assets (ttm)

    11.91%

  • Return on Equity (ttm)

    22.39%

  • Revenue (ttm)

    4.58B

  • Net Income Avi to Common (ttm)

    958.38M

  • Diluted EPS (ttm)

    6.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    237.91M

  • Total Debt/Equity (mrq)

    25.21%

  • Levered Free Cash Flow (ttm)

    934.32M

Research Analysis: RMD

Analyst Price Targets

164.00 Low
202.68 Average
218.06 Current
227.00
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: RMD

Fair Value

218.06 Current
 

Dividend Score

0 Low
RMD
Sector Avg.
100 High
 

Hiring Score

0 Low
RMD
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
RMD
Sector Avg.
100 High
 

Research Reports: RMD

  • Analyst Report: ResMed Inc.

    ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

    Rating
    Price Target
     
  • RMD: Lowering target price to $193.00

    RESMED INC has an Investment Rating of HOLD; a target price of $193.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • RMD: Lowering target price to $194.00

    RESMED INC has an Investment Rating of HOLD; a target price of $194.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • RMD: Raising target price to $204.00

    RESMED INC has an Investment Rating of HOLD; a target price of $204.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     

People Also Watch